Significance of erythrocytes phosphatidylserine exposure on occurrence of anemia in sepsis

Chinese Critical Care Medicine

Volumn 25, Issue 10, 2013, Pages 614-617

  Shi, Bin ^a   Ma, Guo Guang ^a   Liu, Hong Xiang ^a   Liu, Jing Quan ^a   Yang, Wan Hua ^a   Zhang, Hong Ze ^a   Wang, Fing ^a   Wan, Sheng Xia ^a  

^a Shanghai Songjiang District Central Hospital   (China)

Author keywords

Anemia; Erythrocytes; Phosphatidylserine; Sepsis

Indexed keywords

ANNEXIN; HEMOGLOBIN; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE;

ANEMIA; ARTICLE; CLINICAL TRIAL; ERYTHROCYTE; FLOW CYTOMETRY; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; SEPSIS; VENOUS BLOOD;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; PROGNOSIS; SEPSIS;

EID: 84892171962     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.2095-4352.2013.10.009     Document Type: Article

References (24)

1. Corwin HL, Krantz SB Anemia of the critically ill: "acute" anemia of chronic disease. Crit Care Med, 2000, 28:3098-3099.
2. Vincent JL, Piagnerelli M. Transfusion in the intensive care unit. Crit Care Med, 2006, 34: S96-101.
3. van de Wiel A. Anemia in critically ill patients. Eur J Intern Med, 2004, 15: 481-486.
4. Lang KS, Lang PA, Bauer C, et al Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem, 2005, 15: 195-202.
5. Dellinger RP, Levy MM, Carlet JM, et al Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med, 2008, 36:296-327.
6. Grimm C, Wenzel A, Groszer M, et al HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med, 2002, 8: 718-724.
7. Bonomini M, Sirolli V, Settefrati N, et al Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol, 1999, 10: 1982-1990.
8. van Engeland M., Nieland LJ, Ramaekers FC, et al Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry, 1998, 31: 1-9.
9. Lauber K, Blumenthal SG, Waibel M, et al Clearance of apoptotic cells: getting rid of the corpses. Mol Cell, 2004, 14: 277-287.
10. Arese P, Turrini F, Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem, 2005, 16: 133-146.
11. Lang F, Gulbins E, Lang PA, et al Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem, 2010, 26: 21-28.
12. Lang F, Qadri SM Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif, 2012, 33: 125-130.
13. Meier P, Dayer E, Blanc E, et al Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol, 2002, 13: 204-212.
14. Lucchi L, Bergamini S, Iannone A, et al Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif Organs, 2005, 29: 67-72.
15. Siems W, Carluccio F, Radenkovic S, et al Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment. Kidney Blood Press Res, 2005, 28: 295-301.
16. Sakthivel R, Farooq SM, Kalaiselvi P, et al Investigation on the early events of apoptosis in senescent erythrocytes with special emphasis on intracellular free calcium and loss of phospholipid asymmetry in chronic renal failure. Clin Chim Acta, 2007, 382: 1-7.
17. Bi SH, Cheng LT, Wang T. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients. Ren Fail, 2006, 28: 573-576.
18. Bonomini M, Sirolli V, Reale M, et al Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes. Am J Kidney Dis, 2001, 37: 807-814.
19. Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, et al Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med, 2001, 29: 870-877.
20. Takeda K, Shimada Y, Amano M, et al Plasma lipid peroxides and alpha-tocopherol in critically ill patients. Crit Care Med, 1984, 12: 957-959.
21. 2 in the regulation of programmed erythrocyte death. Cell Death Differ, 2005, 12: 415-428.
22. Lang PA, Kempe DS, Tanneur V, et al Stimulation of erythrocyte ceramide formation by platelet-activating factor. J Cell Sci, 2005, 118: 1233-1243.
23. Fadok VA, Bratton DL, Rose DM, et al A receptor for phosphatidylserine- specific clearance of apoptotic cells. Nature, 2000, 405: 85-90.
24. Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci US A, 1998, 95: 3077-3081.